Appointed
Brendan Shanahan
Chief Financial Officer
GOCO ·
GoHealth, Inc.
appointed Brendan Shanahan as the Company’s Chief Financial Officer, effective October 14, 2024
Ready 8-Ks
21
Latest filing
March 31, 2026, 7:59 PM ET
Top materiality
0.90
Event mix
earnings ×7 · leadership ×6 · debt ×2
Sentiment
8 pos · 2 neg · 11 neu
Latest earnings
reported 2025-Q3
Executive change
recent →
Recent 8-K filings for GOCO
Highest-materiality recent filing
GoHealth secures $115M superpriority term loan, amends credit agreement, and appoints three new directors
- Secured $115M superpriority term loan facility with $80M in new-money term loans and $35M in roll-up loans.
- Amended existing credit agreement to waive principal payments through 2026 and reset financial covenants.
-
No GAAP or adjusted EPS, revenue, or net income provided in the press release.
-
GoHealth receives Nasdaq delisting notice for failure to meet $35M market value requirement
Notice dated March 18, 2026 for non-compliance with MVLS Requirement (min $35M market value of listed securities).
-
GoHealth reports Q3 2025 results with intentional MA volume pullback; no financial figures disclosed
Intentionally reduced Medicare Advantage volume in response to health plan focus on renewal stability and unit economics.
-
GoHealth appoints Mark Weinsten and Bao Truong to board; Gelber and Modi resign
Jeremy W. Gelber and Abhiraj Modi resigned from the Board effective August 19, 2025; no disagreement with company.
-
Secured $115M superpriority term loan facility with $80M in new-money term loans and $35M in roll-up loans.
-
Extends revolving credit maturity from June 30 to September 30, 2025, and waives financial covenant testing for Q2 and Q3 2025.
-
Elected Brandon M. Cruz, Alan Wheatley, and Abhiraj R. Modi as Class II directors with >95% of votes cast.
-
GoHealth Q1 net revenue $221M (+19% YoY); Adjusted EBITDA $42.1M (+56%)
Net revenue $221.0M, up 19.1% YoY from $185.6M; net loss narrowed to $9.8M from $21.3M.
-
GoHealth extends CEO Kotte's contract to 2028; $1M salary, $5M equity, $3M cash retention
CEO term extended to April 1, 2028; base salary raised to $1M per year.
-
GoHealth Q4 net revenue up 41% to $389M; net income $58M vs prior year loss
Q4 net revenues $389.1M (+41% YoY); full-year net revenues $798.9M (+9% YoY).
-
GoHealth Q3 net income $15.4M vs loss $56.2M; acquires e-TeleQuote at bargain gain $77.4M
Q3 net revenues $118.3M, down $13.7M from $132.0M a year ago.
-
GoHealth appoints Brendan Shanahan as CFO; O'Halloran becomes CAO
Brendan Shanahan appointed CFO effective Oct 14, 2024; has 30+ years financial leadership and Medicare Advantage expertise.
-
GoHealth closes acquisition of e-TeleQuote; gains ~$100M in contract assets and $18M cash
Acquisition closed on Sept 30, 2024; GoHealth invested $5M for newly issued shares and became sole owner after previous owner relinquished 81.1% stake.
-
GoHealth to acquire e-TeleQuote Insurance, gaining full ownership by Sept 30, 2024
GoHealth subsidiary will acquire newly issued shares representing ~18.9% of e-TeleQuote, then current parent surrenders all rights, making ETQ wholly-owned.
-
GoHealth Q2 2024 net revenues $105.9M, down 26% YoY; net loss improves to $59.3M
Net revenues of $105.9M, a decrease of $36.9M from $142.8M in Q2 2023.
-
GoHealth appoints two new directors, Alan Wheatley and Abhiraj Modi; Christopher Litchford resigns
Alan Wheatley, former President of Medicare at Humana (1991-2022), appointed as Class II director effective July 9, 2024.
-
Joseph G. Flanagan resigned from Board effective June 25, 2024; served as Class II director and Chair of Nominating and Corporate Governance Committee.
-
GoHealth awards interim CFO Katherine O'Halloran $75k bonus and 25k RSUs
Former CFO Jason Schulz resigned effective June 4, 2024; Katherine O'Halloran appointed interim CFO.
-
Alexander Timm (17.6M for), David Fisher (17.3M for), Vijay Kotte (17.8M for) elected Class I directors.
-
GoHealth CFO Jason Schulz resigns; CAO Katherine O'Halloran named interim CFO
Jason Schulz resigned as CFO effective June 4, 2024, for personal reasons; no disagreement with company.
-
GoHealth Q1 net revenues $185.6M, up slightly; net loss narrows to $21.3M
Net revenues of $185.6M vs $183.2M in Q1 2023, a slight increase.
Executive changes
Role change
Katherine O'Halloran
Chief Accounting Officer
GOCO ·
GoHealth, Inc.
Ms. O’Halloran, the Company’s current Interim Chief Financial Officer, will continue her service to the Company as Chief Accounting Officer following Mr. Shanahan’s appointment as Chief Financial Officer.
Appointed
Alan Wheatley
Director
GOCO ·
GoHealth, Inc.
On July 9, 2024, the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”) appointed Alan Wheatley as a Class II director of the Board, effective immediately.
Departed
Christopher C. Litchford
Director
GOCO ·
GoHealth, Inc.
On July 8, 2024, Christopher C. Litchford, a member of the Board, informed the Company of his intent to resign from the Board effective July 8, 2024.
Appointed
Abhiraj R. Modi
Director
GOCO ·
GoHealth, Inc.
On July 9, 2024, the Board appointed Abhiraj R. Modi as a Class II director of the Board.
Departed
Joseph G. Flanagan
Director
GOCO ·
GoHealth, Inc.
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
Role change
Alexander Timm
Lead Independent Director
GOCO ·
GoHealth, Inc.
Alexander Timm will replace Mr. Flanagan as lead independent director.
Departed
Jason Schulz
Chief Financial Officer
GOCO ·
GoHealth, Inc.
On June 4, 2024, GoHealth, Inc. (the “Company”) announced the resignation of Jason Schulz as Chief Financial Officer.
Appointed
(interim)
Katherine O'Halloran
Interim Chief Financial Officer
GOCO ·
GoHealth, Inc.
The Company further announced the appointment of Chief Accounting Officer, Katherine O’Halloran, age 53, as the Interim Chief Financial Officer on June 4, 2024 while the Company searches for a permanent replacement.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.90 · Median 0.65 · Most common event earnings